Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500114712) titled 'explore the clinical efficacy of Spicichibant in the treatment of perennial allergic rhinitis' on Dec. 17, 2025.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: The Ninth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Condition:
Allergic rhinitis
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2025-12-18
Target Sample Size: Experimental Group:60;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=300433
Published by HT Digital Content Services with permission from Heal...